← Eichor
Study identifier: NCT06679036 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients

Condition: Advanced Unresectable or Metastatic Breast Cancer  ·  Sponsor: Shandong Suncadia Medicine Co., Ltd.

PhasePhase 1/Phase 2
Planned participants300
Who can joinFemale, 18 Years to 75 Years
Healthy volunteersNo

About this study

The study is being conducted to evaluate the efficacy, and safety of dexmedetomidine hydrochloride nasal spray for preoperative sedation in adults. To explore the reasonable dosage of dexmedetomidine hydrochloride nasal spray for preoperative sedation.

This description comes directly from the study's public registry record.

Talk to the study team

Xia Zhang, M.M  ·  +86-0518-81220121  ·  xia.zhang@hengrui.com

Always discuss trial participation with your own doctor first.

Locations (2)

Harbin Medical University Affiliated Cancer HospitalHarbin, Heilongjiang, ChinaRecruiting
Henan Cancer HospitalZhengzhou, Henan, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06679036